Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FOXM1 mediates resistance to docetaxel in gastric cancer via up-regulating Stathmin.

Journal of cellular and molecular medicine - 1 May 2014

Li Xiaoxiao, Yao Ruyong, Yue Lu, Qiu Wensheng, Qi Weiwei, Liu Shihai, Yao Yasai, Liang Jun

Abstract excerpt

Docetaxel is commonly used as an effective chemotherapeutic drug for gastric cancer patients recently. With the increasing emergence of docetaxel resistance nowadays, identification of suitable biomarkers for predicting chemosensitivity to docetaxel may be a key role for improving therapeutic eff...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Docetaxel
Share to Forkhead Transcription Factors
Share to Gastrectomy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kinesins

Share to Microtubules

Share to Proportional Hazards Models

Share to Stathmin

Share to Taxoids

Source

Open in PubMed Open full text

Identifiers

PMID: 24628949
DOI: 10.1111/jcmm.12216
PMCID: PMC4119387

Genes

FOXM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24628949-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

FOXM1 mediates resistance to docetaxel in gastric cancer via up-regulating Stathmin.PMID 24628949Read ↗

Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel.Semantic proximity Read ↗

FOXM1 increases hTERT protein stability and indicates poor prognosis in gastric cancerSemantic proximity Read ↗

Silencing MASTL Inhibits Cell Proliferation and Migration of Gastric Cancer MGC-803 Cells Via Suprressing AKT, mTOR, p38 Signal PathwaysSemantic proximity Read ↗

hTERT promotes the invasion of gastric cancer cells by enhancing FOXO3a ubiquitination and subsequent ITGB1 upregulationSemantic proximity Read ↗

The relationships between the chemosensitivity of human gastric cancer to paclitaxel and the expressions of class III β-tubulin, MAPT, and survivinSemantic proximity Read ↗

Twist1 Promotes Gastric Cancer Cell Proliferation through Up-Regulation of FoxM1Semantic proximity Read ↗

Microtubule Engagement with Taxane Is Altered in Taxane-Resistant Gastric CancerSemantic proximity Read ↗

FoxM1 Is a General Target for Proteasome InhibitorsSemantic proximity Read ↗

The effect of paclitaxel on apoptosis, autophagy and mitotic catastrophe in AGS cellsSemantic proximity Read ↗

Downregulation of metastasis suppressor 1(MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.